Copyright Reports & Markets. All rights reserved.

Global Oral Typhoid Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oral Typhoid Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Live-attenuated Vaccine
    • 1.3.3 Live Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Oral Typhoid Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Adults
    • 1.4.3 Children
    • 1.4.4 Elderly
  • 1.5 Global Oral Typhoid Vaccine Market Size & Forecast
    • 1.5.1 Global Oral Typhoid Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Oral Typhoid Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Oral Typhoid Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Berna Biotech
    • 2.1.1 Berna Biotech Details
    • 2.1.2 Berna Biotech Major Business
    • 2.1.3 Berna Biotech Oral Typhoid Vaccine Product and Services
    • 2.1.4 Berna Biotech Oral Typhoid Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Berna Biotech Recent Developments/Updates
  • 2.2 Emergent BioSolutions
    • 2.2.1 Emergent BioSolutions Details
    • 2.2.2 Emergent BioSolutions Major Business
    • 2.2.3 Emergent BioSolutions Oral Typhoid Vaccine Product and Services
    • 2.2.4 Emergent BioSolutions Oral Typhoid Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Emergent BioSolutions Recent Developments/Updates

3 Competitive Environment: Oral Typhoid Vaccine by Manufacturer

  • 3.1 Global Oral Typhoid Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Oral Typhoid Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Oral Typhoid Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Oral Typhoid Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Oral Typhoid Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Oral Typhoid Vaccine Manufacturer Market Share in 2025
  • 3.5 Oral Typhoid Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Oral Typhoid Vaccine Market: Region Footprint
    • 3.5.2 Oral Typhoid Vaccine Market: Company Product Type Footprint
    • 3.5.3 Oral Typhoid Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oral Typhoid Vaccine Market Size by Region
    • 4.1.1 Global Oral Typhoid Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Oral Typhoid Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Oral Typhoid Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Oral Typhoid Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Oral Typhoid Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Oral Typhoid Vaccine Consumption Value (2021-2032)
  • 4.5 South America Oral Typhoid Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Oral Typhoid Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Oral Typhoid Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Oral Typhoid Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Oral Typhoid Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Oral Typhoid Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Oral Typhoid Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Oral Typhoid Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Oral Typhoid Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Oral Typhoid Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Oral Typhoid Vaccine Market Size by Country
    • 7.3.1 North America Oral Typhoid Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Oral Typhoid Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Oral Typhoid Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Oral Typhoid Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Oral Typhoid Vaccine Market Size by Country
    • 8.3.1 Europe Oral Typhoid Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Oral Typhoid Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oral Typhoid Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Oral Typhoid Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Oral Typhoid Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Oral Typhoid Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Oral Typhoid Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Oral Typhoid Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Oral Typhoid Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Oral Typhoid Vaccine Market Size by Country
    • 10.3.1 South America Oral Typhoid Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Oral Typhoid Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oral Typhoid Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Oral Typhoid Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Oral Typhoid Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Oral Typhoid Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Oral Typhoid Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Oral Typhoid Vaccine Market Drivers
  • 12.2 Oral Typhoid Vaccine Market Restraints
  • 12.3 Oral Typhoid Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oral Typhoid Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oral Typhoid Vaccine
  • 13.3 Oral Typhoid Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oral Typhoid Vaccine Typical Distributors
  • 14.3 Oral Typhoid Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oral Typhoid Vaccine market size was valued at US$ 40.1 million in 2025 and is forecast to a readjusted size of US$ 54.01 million by 2032 with a CAGR of 4.4% during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Oral Typhoid Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oral Typhoid Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Typhoid Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Typhoid Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Typhoid Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oral Typhoid Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oral Typhoid Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Berna Biotech, Emergent BioSolutions, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Oral Typhoid Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Live-attenuated Vaccine
    Live Vaccine
    Market segment by Application
    Adults
    Children
    Elderly
    Major players covered
    Berna Biotech
    Emergent BioSolutions
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Oral Typhoid Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Oral Typhoid Vaccine, with price, sales quantity, revenue, and global market share of Oral Typhoid Vaccine from 2021 to 2026.
    Chapter 3, the Oral Typhoid Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Oral Typhoid Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Typhoid Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Typhoid Vaccine.
    Chapter 14 and 15, to describe Oral Typhoid Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now